SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Non-clinical testing for the SARS-CoV-2 virus has been a major goal for regulators across the globe for months. Emergency use authorization (EUA) was just granted by the FDA is for the Quidel Quickvue ...
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the ...
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)-- AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced that its Activ-Film™ ...
SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho (QDEL)"), a leading global provider of ...
Quidel Corporation QDEL recently announced that it will make its non-prescription QuickVue At-Home OTC COVID-19 Test available to consumers from the next week. The test will be available at more than ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has entered the second year and is marked by the emergence of several new and more infectious variant lineages. Many of these ...
Innovative biomedical and pharmaceutical companies rushed to create accurate at-home tests to detect COVID-19 at home in 15 minutes or less. Since the first Abbott BinaxNOW COVID-19 testing kits were ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback